Washington [US], December 15 (ANI): US President Joe Biden on Tuesday (local time) said that Pfizer's COVID-19 antiviral pill mark a significant step forward in the path out of the pandemic.
Zurich [Switzerland], December 11 (ANI/Sputnik): The Swiss Agency for Therapeutic Products, Swissmedic on Friday approved the use of the Pfizer vaccine for children aged 5-11.
New York [US]/Mainz [Germany], December 9 (ANI): A preliminary laboratory study demonstrated that three doses of the Pfizer-BioNTech COVID-19 vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralization titers.
Buenos Aires [Argentina], December 6 (ANI/Sputnik): Two newborns in Brazil were given coronavirus vaccine shots by mistake and had to be hospitalized, Brazilian media report.
Tokyo [Japan], December 6 (ANI): Japan to lessen the present vaccine interval of eight months between the second and third COVID-19 vaccine shots, in the wake of rising Omicron scare.
Islamabad [Pakistan], November 29 (ANI): Amid the global concern of the new COVID variant omicron, Pakistan's Sindh province has decided to inoculate all people with a booster shot of Pfizer.
London [UK], November 28 (ANI): A new research has discovered a gradual increase in the risk of COVID-19 infection from 90 days after receiving a second dose of the Pfizer-BioNTech vaccine.
Washington [US], November 27 (ANI): The pharmaceutical companies Pfizer and BioNTech on Saturday issued a statement stating that they are not sure whether their vaccines would be able to help in the treatment of the new COVID-19 variant 'Omicron'.
London [UK], November 25 (ANI): A new study has found a gradual increase in the risk of COVID-19 infection from 90 days after receiving a second dose of the Pfizer-BioNTech vaccine.
Kathmandu [Nepal], November 23 (ANI): Nepal has started inoculating its teenage population with anti-COVID vaccines. On Monday, those between 12 and below 18 years stood in line to get jabbed as the government rolled the US donated Pfizer vaccine for teenagers or adolescents.
Washington [US], November 22 (ANI): A new study has found that people who received two doses of the Pfizer COVID-19 vaccine while on TNF inhibitors (a class of immunosuppressants), generated less powerful and shorter-lived antibodies against the virus that causes COVID-19 than healthy people